Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hepatitic B Vaccines
Researchers from National Taiwan University, Department of Pediatrics report details of new studies and findings in the area of hepatitic b vaccines
August 6th, 2008
Investigators publish new data in the report 'Inadequate humoral immunogenicity to recombinant hepatitis B virus vaccine in biliary atresia children.' According to a study from Taipei, People's Republic of China, "This study aimed to investigate the primary immunogenicity and the long-term efficacy of recombinant hepatitis B virus (HBV) vaccine in biliary atresia (BA) children. Fifty BA infants (age, 11 ±3.9 mo), and 23 BA patients at childhood (age, 8.5 ±0.22 y) were included for the evaluation of HBV surface antibody (anti-HBs) levels after three doses of recombinant HBV vaccine immunization." "Age-and gender-matched healthy infants (n=50) and children...
Source: Vaccine Weekly (2008-08-06)
|
